Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ADM buys Solae’s soy

This article was originally published in The Tan Sheet

Executive Summary

Decatur, Ill.-based Archer Daniels Midland has purchased Solae's soy isoflavone business, the firms announce Feb. 15. The acquisition includes "an extensive portfolio of U.S. patents, numerous foreign equivalents and pending applications," ADM says. The deal was reached under a settlement in an isoflavone concentrate patent infringement lawsuit Solae filed against ADM in 2003. Solae was created as a joint venture between Dupont and Bunge in January 2003 (1"The Tan Sheet" Jan. 20, 2003, In Brief)...

You may also be interested in...

DuPont/Bunge soy alliance

Joint venture Solae will focus on production of specialty proteins including soy concentrates, lecithins and isolates, partners DuPont and agribusiness company Bunge report. Firms anticipate annual revenues of more than $800 mil. for venture. St. Louis-based Solae is expected to launch this spring...

Eyes On Pricing As Zolgensma Moves Closer To Japan Market

Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.

QUOTED. 28 February 2020. Jubilee Brown.

Laparoscopic power morcellation to remove uterine fibroids should only be performed with the use of a compatible containment system, and only on women younger than 50, the US FDA said in a newly published safety communication and draft guidance document. See what the president of the gynecologic trade group AAGL, Jubilee Brown, said about it here.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts